Top Low Dose Naltrexone Practitioners to Speak at LDN Research Trust’s 4th AIIC LDN Conference in Portland, Oregon, USA

Portland, OR, May 01, 2017 --(PR.com)-- The LDN Research Trust, the non-profit organization and charity dedicated to raising awareness of Low Dose Naltrexone (LDN) as well as funding research and clinical trials of LDN.

It is hosting their 4th AIIC LDN 2017 in September 21-24, 2017 at the Sheraton Airport Hotel, Portland, Oregon. This unique event will feature the latest information from a panel of 29 researchers and health care providers, on topics ranging from practical advice about the dosing and biological action of LDN, to the latest research on and experience with the use of LDN to treat a wide variety of conditions.

Admission to the conference includes online access to 14.75 hours of additional recorded sessions and 20 hours of recorded case studies. As a bonus for attendance, Naturopath Doctors (with upgraded tickets to claim certificates) will receive full certificated credits from either the Oregon Board of Naturopathic Medicine or American Association of Naturopathic Practitioners, and much more.

Attendees will have the opportunity to visit the conference Expo Zone, dedicated to showcasing products and services from leading pharmacy companies from USA and Canada. The Event Sponsor is Enovex Total Wellness Pharmacy. from CA, USA. Their Founder, Dr Ike stated, "As a compounding pharmacist, your job satisfaction is seeing the medications that you prepare make a difference, change lives and provide hope and relief for your patients. LDN is one of those medications, when prepared and used properly will give one of the best results. We are passionate about compounding and very optimistic about LDN and all the possibilities that it can offer to our patients. LDN is one of the most common compound we make in our pharmacy and being a sponsor for the biggest event of the year was a natural extension of our pharmacy practice.”

This is the 4th time Dr Mark Mandel will be the MC at LDN 2017. Dr Mandel is a pharmacist who specializes in Bio-Identical Hormone Replacement Therapy, Weight Loss and Management, Pain Management and the treatment of chronic health conditions with an integration of conventional care, adjunctive therapies and Natural Pharmaceutical Alternatives. He is the owner and president of Mark Drugs and co-host of the weekly radio health show, “The Dr and the Pharmacist,” AM 1160. Dr Mandel is thrilled to support this conference again, “I believe in approaching patient care from a 'ground up' point of view; that traditional medicine tends to treat chronic illness with a reactive approach vs a proactive one that addresses the real culprit, the source of the problem. I believe that LDN can enhance patient care and quality of life.”

Linda Elsegood, Trustee and founder of LDN Research Trust added, “We are grateful to have so many expert speakers support our special event this year. We already have bookings from UK, Canada, Germany as well as the USA and we are hopeful that some of local medical students might make plans to attend. Reduced ticket prices for students, Student Group Discounts are offered. For those people unable to travel and attend the 3 day conference we will be offering our global Live Stream Service. People can watch live, or at their leisure as content will remain online for 12 months. For those booking by May 21st they save $30 off the already low price tickets.”

LDN Research Trust looks forward to welcoming medical professionals, patients, MD’s, NDs and DO’s at its' conference where attendees will hear compelling examples, experiences and case studies from many of the world’s leading experts, practitioners and patients who are using LDN as treatment for a range of immune-related diseases and in many cases achieving positive, life-changing results.

Learn more about the event:
www.LDN2017.com

About LDN Research Trust
The LDN Research Trust is a non-profit, Registered Charity dedicated to raising awareness of Low Dose Naltrexone (LDN) as well as funding research and clinical trials of LDN as a treatment for Multiple Sclerosis, Crohn's Disease, Colitis, Autism, IBS, Lupus, Fibromyalgia, Rheumatoid Arthritis, Chronic Pain and other autoimmune diseases. Over 1 million people are using LDN to achieve positive, and in many cases, life changing results.